短期瘤内及瘤周时空CT影像组学预测非小细胞肺癌新辅助化免疫治疗主要病理缓解
本研究纳入两个中心352例接受新辅助化免疫治疗后根治性手术的非小细胞肺癌患者,构建训练组186例、内部验证组80例和外部验证组86例,利用瘤内及瘤周CT影像组学特征和Delta特征建立支持向量机短期时空模型预测主要病理缓解。多时间点模型在训练组、内部验证组和外部验证组的AUC分别为0.84、0.77和0.75,显著优于RECIST模型和治疗前模型(P<0.05)。
要点
- 多时间点时空模型(治疗前+治疗后+Delta特征)预测MPR的AUC在训练组0.84、内部验证组0.77、外部验证组0.75。
- 该模型显著优于RECIST模型和治疗前模型,P<0.05。
- 短期瘤内及瘤周CT影像组学有望作为无创工具评估治疗反应。
核心结论
- 短期瘤内及瘤周CT影像组学的时序分析是预测NSCLC新辅助化免疫治疗主要病理缓解的有前景方法,影像组学有潜力作为无创工具评估治疗反应并指导个体化治疗。
研究设计与样本
- 研究纳入两个中心共352例接受新辅助化免疫治疗后根治性手术的NSCLC患者,分为训练组186例、内部验证组80例和外部验证组86例;计算瘤内及瘤周CT影像组学特征和Delta影像组学特征,采用支持向量机分类器构建短期时空模型。
诊断标准与关键数值
- 多时间点短期时空模型(纳入治疗前、治疗后和Delta影像组学特征)在训练组AUC为0.84、内部验证组AUC为0.77、外部验证组AUC为0.75。
- 该模型显著优于RECIST模型和治疗前模型,P值<0.05。
临床应用与阅片要点
- 作者认为短期瘤内及瘤周CT影像组学是预测NSCLC新辅助化免疫治疗主要病理缓解的有前景方法。
- 作者指出这些发现强调影像组学有潜力作为无创工具评估治疗反应并指导NSCLC患者个体化治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study aims to develop a short-term spatiotemporal CT radiomics model to predict the major pathological response (MPR) to neoadjuvant chemoimmunotherapy (NCI) in NSCLC by decoding the intra- and peri-tumoral imaging phenotypes.
METHODS: A total of 352 patients undergoing curative surgery following NCI for NSCLC were enrolled from two centers, forming a training cohort (n = 186), an internal validation cohort (n = 80), and an external validation cohort (n = 86). Intra- and peri-tumoral CT radiomics features were computed to capture imaging phenotypes of the tumor microenvironment. Delta radiomics features were also calculated by quantifying changes in each radiomics feature. A support vector machine classifier was utilized to develop the short-term spatiotemporal model by analyzing changes in radiomics features.
RESULTS: The multi-timepoint short-term spatiotemporal model, incorporating pre-treatment, post-treatment and delta radiomic features, achieved AUC values of 0.84, 0.77, and 0.75 in the training, internal validation, and external validation cohorts, respectively. These results significantly outperformed the RECIST model and pre-treatment model, with p-values < 0.05 indicating statistical significance.
CONCLUSION: This study demonstrates that short-term temporal analysis of intra- and peri-tumoral CT radiomics is a promising approach for predicting MPR to NCI in NSCLC. These findings underscore the potential of radiomics as a non-invasive tool for assessing treatment response and guiding personalized therapy in NSCLC patients.
KEY POINTS: Question Neoadjuvant chemoimmunotherapy has improved in major pathological response rate for non-small cell lung cancer (NSCLC), but it is unclear which patients will benefit most. Findings The multi-timepoint short-term spatiotemporal model based on CT pictures demonstrates high predictive performance for assessing major pathological response following neoadjuvant chemoimmunotherapy in NSCLC. Clinical relevance Short-term intra- and peri-tumoral CT radiomics is a promising approach for predicting major pathological response to neoadjuvant chemoimmunotherapy in NSCLC. These findings underscore the potential of radiomics as a non-invasive tool for assessing treatment response in NSCLC.
引用
- Bao X, Peng Q, Bian D, et al. Short-term intra- and peri-tumoral spatiotemporal CT radiomics for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer. Eur Radiol. 2025. PMID: 40214734. doi:10.1007/s00330-025-11563-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。